CIK 0001237831 · Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043744954
- Phone
- 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,970,014
- in 4 filings, $425K under 10b5-1 plans
Net −$7,970,014. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-10 | Lemaitre Dan Director | Sale | −63,300 | $64.61 | $4.1M | 0 |
| 2024-05-10 | Lemaitre Dan Director | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −17,500 | 0 | ||
| 2024-05-10 | Lemaitre Dan Director | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −17,500 | 0 | ||
| 2024-05-10 | Lemaitre Dan Director | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −17,500 | 0 | ||
| 2024-05-08 | Davidar David D Director | Sale 10b5-1 | −20,000 | $65.00 | $1.3M | 566,275 |
| 2024-03-15 | Norwalk Leslie V Director | Sale 10b5-1 | −10,590 | $51.99 | $551K | 17,419 |
| 2024-03-01 | Huller Kelly SVP, GC, Corporate Secretary | Option exercise 10b5-1 | +7,500 | $24.90 | $187K | 7,500 |
| 2024-03-01 | Huller Kelly SVP, GC, Corporate Secretary | Sale 10b5-1 | −4,385 | $53.79 | $236K | 3,115 |
| 2024-03-01 | Huller Kelly SVP, GC, Corporate Secretary | Sale 10b5-1 | −3,115 | $54.53 | $170K | 0 |
| 2024-03-01 | Huller Kelly SVP, GC, Corporate Secretary | Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | −7,500 | 0 | ||
| 2024-01-26 | Wolterman Dan Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2024-01-26 | Norwalk Leslie V Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2024-01-26 | ZARRILLI STEPHEN T Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2024-01-26 | Douglas Robert Andrew Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2024-01-26 | Davidar David D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2024-01-26 | Lemaitre Dan Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2024-01-26 | TOBIN JAMES R Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2024-01-26 | RHOADS ANN D Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2024-01-26 | DeFord John A Director | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +15,000 | 15,000 | ||
| 2024-01-26 | Huller Kelly SVP, GC, Corporate Secretary | Grant or award · Stock Option (Right to Buy Class A Common Stock) | +40,000 | 40,000 |
Page 8 of 10 · 200 trades